India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD
Praveen Rao Akkinepally, Managing Director, AstraZeneca Pharma India As biopharmaceutical drugmaker AstraZeneca waits in the wings with its…
ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2
When looking out across the competitive GLP-1 landscape, AstraZeneca might not be the first Big Pharma name that…
Weight loss drugs wipe £780m off Britain’s grocery bills, research shows
The findings draw on responses from more than 11,500 households, and the research marks the third year Worldpanel…
Growing UK demand for GLP-1s is set outstrip NHS capacity
A new survey, compiled by charity and think tank The Food Foundation, has revealed that an estimated 8.25…